Skip to main content

December 2016

 

 

academics

 

Clinical research courses

Job for M.Pharm, M.Sc at Institute of Advanced Study in Science and Technology

Applications with complete bio-data along with photocopies of educational qualifications, address for correspondence with contact phone number are invited for a post of Senior Research Fellow (SRF) from Indian citizen.

Post : Senior Research Fellow

Walk-in Interview at Regional Centre for Biotechnology for Scientist

Regional Centre for Biotechnology (RCB), an institution of education, training and research is established by the Department of Biotechnology, Government of India under the auspices of UNESCO. The Centre will focus on cooperatively working towards shared biotechnology growth in the Asia-Pacific Region. Regional interactions in biotechnology will promote co-operation amongst the countries to develop necessary infrastructure and capacity building for economic benefit of our societies. The Centre would be beneficial in developing knowledge rich, highly skilled human resource to all countries in the region. RCB will be part of the Biotech Science Cluster (BSC) and will operate in synergy with the other institutions in the Cluster.

Career for B.Pharm, M.Pharm as Research Associate at Cliantha

Cliantha is a global Contract Research Organization (CRO) providing an integrated clinical offerings in Early Phase (Phase l/lla), Late Phase (Phase ll-IV), Bioequivalence (BA/BE), Clinical Endpoint Trials, Bioanalytical, Biosimilars, Dermatology, Biometrics, and Personal Healthcare services. Our services have science at its foundation developed through regular and systematic training of the Cliantha team. Cliantha Research offers a comprehensive range of clinicaL research and support services to BiosimiLar, Biotech, Cosmetic, Generic, Personal Healthcare and Pharmaceutical companies.

Post : Research Associate

Applications are invited for post of Junior Research Fellow at IASST

Applications are invited from candidates for position of Junior Research Fellow (JRF) under a DBT funded project “Development of Nanoparticle or microparticle Adjuvanted Subunit Oral vaccine against poultry Salmonellosis” at Physical Sciences Division of Institute of Advanced Study in Science and Technology (IASST), Guwahati

Post : Junior Research Fellow

Job for Solution Consultant - Life Sciences in Thomson Reuters

Thomson Reuters is the leading source of intelligent information for the world's businesses and professionals, providing customers with competitive advantage. Intelligent information is a unique synthesis of human intelligence, industry expertise and innovative technology that provides decision-makers with the knowledge to act, enabling them to make better decisions faster. Through its more than 50,000 people across 93 countries, Thomson Reuters delivers this must-have insight to the financial, legal, tax and accounting, scientific, healthcare and media markets, and is powered by the world's most trusted news organization.

Post: Solution Consultant - Life Sciences

Recruitment for B.Pharm in Big Pharma Consultancy | 10 posts

Big Pharma Jobs is a part of India’s leading HR Consulting company i.e.Big Ideas HR Consulting Pvt. Ltd. Big Pharma Jobs today is India’s No 1 Pharma Recruitment Company with presence in India and overseas across more then 10+ locations with more then 60+ Pharma Domain Experts . Big Pharma Jobs fills the gap in pharma recruitment domain with end to end complete one stop platform eliminating loose ends whether it is Various business segments in Pharma i.e (Formulations, API’s, New Drug Discovery, Biotech, Diagnostics, Contract Research, Clinical Research etc.,) or Functional areas i.e (Corporate, Corporate Support, Manufacturing, Research & Development) Levels (CEO, VP, GM, Manager etc.,) or Locations (India or Overseas).

Post : Product Manager/Group ProductManager - 10 posts

Wanted Lab Technician at Shree Dhanvantary Pharmacy College

Shree Dhanvantary Pharmacy College (SDPC), established in 2005 by Shree Sahkar Education Trust, Surat.  During this brief tenure of eleven years, it has made rapid strides of progress to become one of the premier institutes of Pharmacy in Gujarat. This institute is approved by AICTE, PCI & affiliated to GTU and currently offering B.Pharm, M.Pharm (Pharmaceutical Chemistry, Pharmaceutics, Pharmacology & Quality Assurance), Pharm.D. & Ph. D. courses.

Post : Lab Technician - 03 posts

Job for Accountant at SDPC

Shree Dhanvantary Pharmacy College (SDPC), established in 2005 by Shree Sahkar Education Trust, Surat.  During this brief tenure of eleven years, it has made rapid strides of progress to become one of the premier institutes of Pharmacy in Gujarat. This institute is approved by AICTE, PCI & affiliated to GTU and currently offering B.Pharm, M.Pharm (Pharmaceutical Chemistry, Pharmaceutics, Pharmacology & Quality Assurance), Pharm.D. & Ph. D. courses.

Post : Accountant - 02 posts

EVALUATION OF APHRODISIAC ACTIVITY OF TAMILNADIA ULIGNOSA (RETZ.) BARK

{ DOWNLOAD AS PDF }

ABOUT AUHTORS
Neerugatti Dorababu, Battu Ganga Rao, Devarakonda Ramadevi

A.U. College of Pharmaceutical Sciences, Andhra University,
Visakhapatnam, Andhra Pradesh (A.P), India
*ramapathi.addepalli@gmail.com

ABSTRACT:
The study was aimed at investigate the effect of methanolic extract of Tamilnadia ulignosa (Retz.) (Rubiaceae) on general mating behaviour, libido, and adverse effects on sexually normal male albino rats.  Methanolic extract was administered orally at the dose of 100, 200, and 400 mg / kg, to different groups of male rats (n = 8) once a day for 14 days . All the doses resulted in significant increase in mount frequency, intromission frequency and anogenital sniffing when compared to normal. The methanolic extract of Tamilnadia ulignosa (Retz.) bark at higher concentration (400 mg/kg body weight) showed significant aphrodisiac activity on male Wister albino rats as evidenced by an increase in number of mounts and mating performance. Thus, in experimental rats, the results of the present study suggest that the methanolic extracts of Tamilnadia ulignosa (Retz.) exert significant aphrodisiac activity

Roche announced that the primary endpoint has been met for the phase III HAVEN 1 study evaluating emicizumab prophylaxis in people 12 years of age or older with haemophilia A and inhibitors to factor VIII. The study showed a statistically significant reduction in the number of bleeds over time in people treated with emicizumab prophylaxis compared to those receiving no prophylactic treatment. The study also met all secondary endpoints, including a statistically significant reduction in the number of bleeds over time with emicizumab prophylaxis treatment in an intra-patient comparison in people who had received prior bypassing agent prophylaxis treatment. The most common adverse events with emicizumab were injection site reactions, consistent with prior studies.